hotspot -WSS

hotspot

author：leisure time 2025-08-24 04:09:37 - browse：21

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

entertainment

Wikipedia

WSS

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

The EPA's new lead rule: How one expert crunched the numbers

The EPA's new lead rule: How one expert crunched the numbers

Fetal surgery at risk from Dobbs and new abortion restrictions

30 years of 'Listening to Prozac'

focus

hotspot

focus

In Memoriam: Notable people who died in 2023

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Wildfire smoke exposes gaps in outdoor worker protections

What don’t we know about an Alzheimer’s drug side effect?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Congenital heart disease patients face new threat of heart failure

Virginia high school admissions case could be legal follow

FDA investigates CAR

Hollywood unions extend contract negotiations for actors

AI models in health care face new federal disclosure requirements

knowledge

Teach medical students about patients with intellectual disabilities

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Congenital heart disease patients face new threat of heart failure

Radiology is caught between AI's potential and concern for patients

Diagnostic tests are hitting their mathematical limits

Leukemia patients are helped by Syndax's new type of therapy

entertainment

Wikipedia

knowledge

focus